زائر
السلام عليكم ورحمة الله وبركاته ,
اضع بين يديكم بعض الاسئله التابعه لعلم المناعه لعل وعسى ان يكون بها منفعه لكم ,
1
Fist-ine the defense against antigeni inst
adaptive immne system
innate immne system
2
Adaptive Immne espnse(s):
antibdy pdtin
ymphyte ativatin
bth
neithe
3
Geneatin f speifi immnity eqies antigen-pesenting es, APs, inding:
B ymphytes
maphages
angehans es
A & B
A,B &
4
Pded by TH1 sbsets f T hepe ymphytes:
intefen-gamma
inteekin-2
tm nesis fat beta
A & B
A, B &
5
Typiay assiated with B e pifeatin and diffeentiatin int antibdy-seeting pasma es
tm nesis fat beta
intefen-gamma
I-4 (inteekin 4)
I-2 (inteekin 2)
a f the abve
6
T hepe ymphytes -- egate eah the; this sbstane pded by TH1es inhibits TH2 ea pifeatin:
inteekin-2
tm nesis fat beta
intefen-gamma
I-4
I-6
7
Extaea bateia pmte eabatin f:
TH1 ytkines
TH2 ytkines
8
Intaea ganisms (e.g. Mybateim) pmte pdtin f:
TH1 ytkines
TH2 ytkines
9
Ativated yttxi T es inde taget e death (vis-infeted es) by:
Fas-Fas igand aptsis pathway
yti gane enzymes
pefin
a f the abve
10
Hypesensitivity: ss-inking f membane-bnd IgE n bd basphis tisse mast es by antigen
Type I
Type II
Type III
11
Hemyti disease f the newbn:
Immediate Hypesensitivity Type I
Deayed Hypesensitivity
Immediate Hypesensitivity Type II
Immediate Hypesensitivity Type III
12
Assiated with eevated eves f antigen-antibdy mpexes, whih ase tisse damage; mpement ativatin ests in anaphyatxi and hemtati ativities:
Immediate Hypesensitivity Type III
Immediate Hypesensitivity Type II
Deayed Hypesensitivity
Immediate Hypesensitivity Type I
13
Administatin f peniiin t aegi patients:
Immediate Hypesensitivity Type I
Immediate Hypesensitivity Type II
Immediate Hypesensitivity Type III
14
Effetive in eiminating infetins ased by intaea pathgens sh as eishmania speies:
Immediate Hypesensitivity Type I
Immediate Hypesensitivity Type II
Immediate Hypesensitivity Type III
Deayed Hypesensitivity
15
Exampes f atimmne diseases
hematid athitis
insin-dependent diabetes meits
systemi ps eythematsis
A &
A, B &
أعلى النموذج
1
Exampe f fist-ass f hmna agents nted t have ipyti ppeties:
yspine
pednisne (Detasne)
taims
IFN-apha
thaidmide
2
Gtiid effets:
inhibitin f ektiene pdtin
inhibitin f pstagandins
ineased hemtaxis
A & B
A, B &
3
Effetive in weing inidents f ejetin in infetis mpiatins in tanspant patients:
azathipine (Iman)
pednisne (Detasne)
antiymphyte antibdies
yspine (Sandimmne, Nea)
a the abve
4
Tests f immnmpeteny:-- measements
in vit I-2 stimatin f ymphkine ativated kie e pdtin
in vit ymphyte pfieative espnses t mitgens
eythpiesis
A & B
A, B &
5
Abt tw-thids f hiden with eay diabeti symptms an disntine ede insin teatment within abt six weeks afte stating teatment with this dg:
taims
intefen
yspine (Sandimmne, Nea)
pednisne (Detasne) and
thaidmide
6
This immnsppessant antibiti mmny appved f se in ive tanspantatin, is 10 t 100 times me ptent than yspine in inhibiting immne espnses:
intefen-gamma
pednisne (Detasne)
taims (FK 506)
A & B
A, B &
7
Atimmne (Type II) dg eatin:
peniiin
sfnamides
idides
phenytin (Diantin)
hydaazine (Apesine)
8
Impiated in initiatin f hypesensitivity vasitis; a Type III vasiti eatin:
sfnamides
peniiin
thiai
antinvsants
a the abve
9
Bkade f mediat eease fwing expse f sensitized tisse mast es bd basphis t dgs that initiate Type I dg aegi eatins:
ispteen (Ispe)
antihistamines
thephyine
A &
A, B &
10
Exampe f immnstimaty ytkine that may be sef in ane immntheapy
evamise
BG
IFN-apha
I-2
nne f the abve
11
F synthesized f teating paasiti infetins, this dg is nw FDA appved f inia se in the teatment f Dkes ass eta ane afte sgey:
insipex
thympietin
evamise
BG
IGIV
12
Akyating agent; destys pifeating ymphid es; in w dses -- f effetive against atimmne disdes inding systemi ps eythematss
azathipine (Iman)
methtexate
yphsphamide (ytxan)
antiymphyte gbin (AG)
a the abve
13
yttxi agents with immnsppessive ppeties:
yphsphamide (ytxan)
vinistine (nvin)
methtexate
ytaabine (AA-)
a the abve
14
Type 1 immediate hypesensitivity:
de t eevated eves f antigen-antibdy mpexes
stems fm ss-inking f membane-bnd IgE n bd basphis tisse mast es by antigen
fws fm fmatin f antigen- antibdy mpexes between feign antigen and IgM IgG immngbins
tisse damage de t infx f antigen-nnspeifi infammaty es (maphages and netphis)
15
Atimmne disde: assiated with antibdies made against sef DNA, ed bd es, histnes, pateets
hematid athitis
systemi ps eythematss
insin dependent diabetes
أسفل النموذج
أعلى النموذج
أسفل النموذج
ngenitay-aqied immndefiieny disease
???ass I MH meestisteidsass II MH meesdeayed hypesensitivityhman immndefiieny visDiGege's syndmeType II immediate hypesensitivityTH2ativated yttxi T eeffets f e-mediated immnitysevee mbined immndefiieny disease (SID)Type I hypesensitivityeffets f hma immnity
X
adensine deaminase defiieny
???ass I MH meestisteidsass II MH meesdeayed hypesensitivityhman immndefiieny visDiGege's syndmeType II immediate hypesensitivityTH2ativated yttxi T eeffets f e-mediated immnitysevee mbined immndefiieny disease (SID)Type I hypesensitivityeffets f hma immnity
X
stng tpism f D4+ hepe T es
???ass I MH meestisteidsass II MH meesdeayed hypesensitivityhman immndefiieny visDiGege's syndmeType II immediate hypesensitivityTH2ativated yttxi T eeffets f e-mediated immnitysevee mbined immndefiieny disease (SID)Type I hypesensitivityeffets f hma immnity
X
eatin effetive in eiminating infetins ased by intaea pathgens (e.g. eishmania)
???ass I MH meestisteidsass II MH meesdeayed hypesensitivityhman immndefiieny visDiGege's syndmeType II immediate hypesensitivityTH2ativated yttxi T eeffets f e-mediated immnitysevee mbined immndefiieny disease (SID)Type I hypesensitivityeffets f hma immnity
X
e type assiated with e-mediated immnity
???ass I MH meestisteidsass II MH meesdeayed hypesensitivityhman immndefiieny visDiGege's syndmeType II immediate hypesensitivityTH2ativated yttxi T eeffets f e-mediated immnitysevee mbined immndefiieny disease (SID)Type I hypesensitivityeffets f hma immnity
X
ativated ymphytes
???ass I MH meestisteidsass II MH meesdeayed hypesensitivityhman immndefiieny visDiGege's syndmeType II immediate hypesensitivityTH2ativated yttxi T eeffets f e-mediated immnitysevee mbined immndefiieny disease (SID)Type I hypesensitivityeffets f hma immnity
X
antibdies
???ass I MH meestisteidsass II MH meesdeayed hypesensitivityhman immndefiieny visDiGege's syndmeType II immediate hypesensitivityTH2ativated yttxi T eeffets f e-mediated immnitysevee mbined immndefiieny disease (SID)Type I hypesensitivityeffets f hma immnity
X
I-4, I-5, I-6 pded by this sbset f T es
???ass I MH meestisteidsass II MH meesdeayed hypesensitivityhman immndefiieny visDiGege's syndmeType II immediate hypesensitivityTH2ativated yttxi T eeffets f e-mediated immnitysevee mbined immndefiieny disease (SID)Type I hypesensitivityeffets f hma immnity
X
pesent mainy fagments f ea antigens (e.g. vis tm antigens) pess thgh Ggi appaats
???ass I MH meestisteidsass II MH meesdeayed hypesensitivityhman immndefiieny visDiGege's syndmeType II immediate hypesensitivityTH2ativated yttxi T eeffets f e-mediated immnitysevee mbined immndefiieny disease (SID)Type I hypesensitivityeffets f hma immnity
X
pesent antigen fagments fm intenaized and enzymatiay digested feign antigens
???ass I MH meestisteidsass II MH meesdeayed hypesensitivityhman immndefiieny visDiGege's syndmeType II immediate hypesensitivityTH2ativated yttxi T eeffets f e-mediated immnitysevee mbined immndefiieny disease (SID)Type I hypesensitivityeffets f hma immnity
X
Immediate hypesensitivity type assiated with hemyti disease in the newbn
???ass I MH meestisteidsass II MH meesdeayed hypesensitivityhman immndefiieny visDiGege's syndmeType II immediate hypesensitivityTH2ativated yttxi T eeffets f e-mediated immnitysevee mbined immndefiieny disease (SID)Type I hypesensitivityeffets f hma immnity
X
Immediate hypesensitivity eatin assiated with asthma, hay feve, hives -- fwing bd basphi tisse mast e deganatin
???ass I MH meestisteidsass II MH meesdeayed hypesensitivityhman immndefiieny visDiGege's syndmeType II immediate hypesensitivityTH2ativated yttxi T eeffets f e-mediated immnitysevee mbined immndefiieny disease (SID)Type I hypesensitivityeffets f hma immnity
X
Fist-ass f hmna agents egnized t pssess ymphyti ppeties
Immnphamagy
This is a sef-gading exam. Answes ae enteed by iking the bttn espnding t y seetin. The examinatin is sed by iking 'Gade Test' at the bttm f the fm. et answes ae fnd thgh hypeinks at the bttm f the page.
أعلى النموذج
Qestin # 1 (Mtipe hie) Stta anagantimetabite: yttxi immnsppessive dg:
A) vinistine
B) yphsphamide
) azathipine
D) nne f the abve
Qestin # 2 (Mtipe hie) Immnmdaty sedative dgs sed in the management f sme fms f epsy; as effetive in managing skin manifestatins f ps eythematss
A) taims
B) yphsphamide
) thaidmide
D) bppin
E) diazepam
Qestin # 3 (Mtipe hie) Dg f hie in teating atimmne hemyti anemia:
A) yphsphamide ps fat XIII
B) h(D) immne gbin
) pednisne
D) KT3 mnna antibdy
E) yspine
Qestin # 4 (Mtipe hie) Intefees with e ye f ativated ymphid es;exampe f the fist ass f hmna agents egnized have ymphyti ppeties:
A) yspine
B) taims
) IFN-apha
D) dexamethasne
E) 15-desxyspegain
Qestin # 5 (Mtipe hie) sef in management f idipathi thmbytpeni ppa efaty t pednisne
A) datinmyin
B) vinistine
) yphsphamide
D) azathipine
E) a f the abve
Qestin # 6 (Mtipe hie) Dg f hie in teating hemyti anemia f the newbn:
A) yspine
B) pednisne
) KT3 mnna antibdy
D) taims
E) h(D) immne gbin
Qestin # 7 (Mtipe hie) inia ses f intefen:
A) ane teatment
B) mtipe sesis
) bth
D) neithe
Qestin # 8 (TeFase) Type 1 hypesensitivity: ss-inking f membane-bnd IgE n bd basphis tisse mast es by antigen
A) te
B) fase
Qestin # 9 (Mtipe hie) immnmdating agents:
A) thymsin
B) intefen beta
) intefen-gamma
D) TNF apha
E) a the abve
Qestin # 10 (TeFase) ass 1 MH mees pesent mainy fagments f ea antigens
A) te
B) fase
Qestin # 11 (Mtipe hie) Inhibits antigen egnitin f B-e
A) pednisne
B) azathipine
) methtexate
D) h(D) immne gbin
E) taims
Qestin # 12 (Mtipe hie) Antiymphyte antibdies:
A) binds t the sfae f T es
B) ats mainy n sma, ng-ived peiphea ymphytes
) may be sed in indtin f immnsppessin
D) may be btained by hybidma tehniqe f mnna antibdy geneatin
E) a f the abve
Qestin # 13 (Mtipe hie) inia ses f immnsppessive dgs:
A) gan tanspantatin
B) hemyti disease f the newbn
) atimmne disdes
D) A &
E) A, B &
أسفل النموذج
اضع بين يديكم بعض الاسئله التابعه لعلم المناعه لعل وعسى ان يكون بها منفعه لكم ,
1
Fist-ine the defense against antigeni inst
adaptive immne system
innate immne system
2
Adaptive Immne espnse(s):
antibdy pdtin
ymphyte ativatin
bth
neithe
3
Geneatin f speifi immnity eqies antigen-pesenting es, APs, inding:
B ymphytes
maphages
angehans es
A & B
A,B &
4
Pded by TH1 sbsets f T hepe ymphytes:
intefen-gamma
inteekin-2
tm nesis fat beta
A & B
A, B &
5
Typiay assiated with B e pifeatin and diffeentiatin int antibdy-seeting pasma es
tm nesis fat beta
intefen-gamma
I-4 (inteekin 4)
I-2 (inteekin 2)
a f the abve
6
T hepe ymphytes -- egate eah the; this sbstane pded by TH1es inhibits TH2 ea pifeatin:
inteekin-2
tm nesis fat beta
intefen-gamma
I-4
I-6
7
Extaea bateia pmte eabatin f:
TH1 ytkines
TH2 ytkines
8
Intaea ganisms (e.g. Mybateim) pmte pdtin f:
TH1 ytkines
TH2 ytkines
9
Ativated yttxi T es inde taget e death (vis-infeted es) by:
Fas-Fas igand aptsis pathway
yti gane enzymes
pefin
a f the abve
10
Hypesensitivity: ss-inking f membane-bnd IgE n bd basphis tisse mast es by antigen
Type I
Type II
Type III
11
Hemyti disease f the newbn:
Immediate Hypesensitivity Type I
Deayed Hypesensitivity
Immediate Hypesensitivity Type II
Immediate Hypesensitivity Type III
12
Assiated with eevated eves f antigen-antibdy mpexes, whih ase tisse damage; mpement ativatin ests in anaphyatxi and hemtati ativities:
Immediate Hypesensitivity Type III
Immediate Hypesensitivity Type II
Deayed Hypesensitivity
Immediate Hypesensitivity Type I
13
Administatin f peniiin t aegi patients:
Immediate Hypesensitivity Type I
Immediate Hypesensitivity Type II
Immediate Hypesensitivity Type III
14
Effetive in eiminating infetins ased by intaea pathgens sh as eishmania speies:
Immediate Hypesensitivity Type I
Immediate Hypesensitivity Type II
Immediate Hypesensitivity Type III
Deayed Hypesensitivity
15
Exampes f atimmne diseases
hematid athitis
insin-dependent diabetes meits
systemi ps eythematsis
A &
A, B &
أعلى النموذج
1
Exampe f fist-ass f hmna agents nted t have ipyti ppeties:
yspine
pednisne (Detasne)
taims
IFN-apha
thaidmide
2
Gtiid effets:
inhibitin f ektiene pdtin
inhibitin f pstagandins
ineased hemtaxis
A & B
A, B &
3
Effetive in weing inidents f ejetin in infetis mpiatins in tanspant patients:
azathipine (Iman)
pednisne (Detasne)
antiymphyte antibdies
yspine (Sandimmne, Nea)
a the abve
4
Tests f immnmpeteny:-- measements
in vit I-2 stimatin f ymphkine ativated kie e pdtin
in vit ymphyte pfieative espnses t mitgens
eythpiesis
A & B
A, B &
5
Abt tw-thids f hiden with eay diabeti symptms an disntine ede insin teatment within abt six weeks afte stating teatment with this dg:
taims
intefen
yspine (Sandimmne, Nea)
pednisne (Detasne) and
thaidmide
6
This immnsppessant antibiti mmny appved f se in ive tanspantatin, is 10 t 100 times me ptent than yspine in inhibiting immne espnses:
intefen-gamma
pednisne (Detasne)
taims (FK 506)
A & B
A, B &
7
Atimmne (Type II) dg eatin:
peniiin
sfnamides
idides
phenytin (Diantin)
hydaazine (Apesine)
8
Impiated in initiatin f hypesensitivity vasitis; a Type III vasiti eatin:
sfnamides
peniiin
thiai
antinvsants
a the abve
9
Bkade f mediat eease fwing expse f sensitized tisse mast es bd basphis t dgs that initiate Type I dg aegi eatins:
ispteen (Ispe)
antihistamines
thephyine
A &
A, B &
10
Exampe f immnstimaty ytkine that may be sef in ane immntheapy
evamise
BG
IFN-apha
I-2
nne f the abve
11
F synthesized f teating paasiti infetins, this dg is nw FDA appved f inia se in the teatment f Dkes ass eta ane afte sgey:
insipex
thympietin
evamise
BG
IGIV
12
Akyating agent; destys pifeating ymphid es; in w dses -- f effetive against atimmne disdes inding systemi ps eythematss
azathipine (Iman)
methtexate
yphsphamide (ytxan)
antiymphyte gbin (AG)
a the abve
13
yttxi agents with immnsppessive ppeties:
yphsphamide (ytxan)
vinistine (nvin)
methtexate
ytaabine (AA-)
a the abve
14
Type 1 immediate hypesensitivity:
de t eevated eves f antigen-antibdy mpexes
stems fm ss-inking f membane-bnd IgE n bd basphis tisse mast es by antigen
fws fm fmatin f antigen- antibdy mpexes between feign antigen and IgM IgG immngbins
tisse damage de t infx f antigen-nnspeifi infammaty es (maphages and netphis)
15
Atimmne disde: assiated with antibdies made against sef DNA, ed bd es, histnes, pateets
hematid athitis
systemi ps eythematss
insin dependent diabetes
أسفل النموذج
أعلى النموذج
أسفل النموذج
ngenitay-aqied immndefiieny disease
???ass I MH meestisteidsass II MH meesdeayed hypesensitivityhman immndefiieny visDiGege's syndmeType II immediate hypesensitivityTH2ativated yttxi T eeffets f e-mediated immnitysevee mbined immndefiieny disease (SID)Type I hypesensitivityeffets f hma immnity
X
adensine deaminase defiieny
???ass I MH meestisteidsass II MH meesdeayed hypesensitivityhman immndefiieny visDiGege's syndmeType II immediate hypesensitivityTH2ativated yttxi T eeffets f e-mediated immnitysevee mbined immndefiieny disease (SID)Type I hypesensitivityeffets f hma immnity
X
stng tpism f D4+ hepe T es
???ass I MH meestisteidsass II MH meesdeayed hypesensitivityhman immndefiieny visDiGege's syndmeType II immediate hypesensitivityTH2ativated yttxi T eeffets f e-mediated immnitysevee mbined immndefiieny disease (SID)Type I hypesensitivityeffets f hma immnity
X
eatin effetive in eiminating infetins ased by intaea pathgens (e.g. eishmania)
???ass I MH meestisteidsass II MH meesdeayed hypesensitivityhman immndefiieny visDiGege's syndmeType II immediate hypesensitivityTH2ativated yttxi T eeffets f e-mediated immnitysevee mbined immndefiieny disease (SID)Type I hypesensitivityeffets f hma immnity
X
e type assiated with e-mediated immnity
???ass I MH meestisteidsass II MH meesdeayed hypesensitivityhman immndefiieny visDiGege's syndmeType II immediate hypesensitivityTH2ativated yttxi T eeffets f e-mediated immnitysevee mbined immndefiieny disease (SID)Type I hypesensitivityeffets f hma immnity
X
ativated ymphytes
???ass I MH meestisteidsass II MH meesdeayed hypesensitivityhman immndefiieny visDiGege's syndmeType II immediate hypesensitivityTH2ativated yttxi T eeffets f e-mediated immnitysevee mbined immndefiieny disease (SID)Type I hypesensitivityeffets f hma immnity
X
antibdies
???ass I MH meestisteidsass II MH meesdeayed hypesensitivityhman immndefiieny visDiGege's syndmeType II immediate hypesensitivityTH2ativated yttxi T eeffets f e-mediated immnitysevee mbined immndefiieny disease (SID)Type I hypesensitivityeffets f hma immnity
X
I-4, I-5, I-6 pded by this sbset f T es
???ass I MH meestisteidsass II MH meesdeayed hypesensitivityhman immndefiieny visDiGege's syndmeType II immediate hypesensitivityTH2ativated yttxi T eeffets f e-mediated immnitysevee mbined immndefiieny disease (SID)Type I hypesensitivityeffets f hma immnity
X
pesent mainy fagments f ea antigens (e.g. vis tm antigens) pess thgh Ggi appaats
???ass I MH meestisteidsass II MH meesdeayed hypesensitivityhman immndefiieny visDiGege's syndmeType II immediate hypesensitivityTH2ativated yttxi T eeffets f e-mediated immnitysevee mbined immndefiieny disease (SID)Type I hypesensitivityeffets f hma immnity
X
pesent antigen fagments fm intenaized and enzymatiay digested feign antigens
???ass I MH meestisteidsass II MH meesdeayed hypesensitivityhman immndefiieny visDiGege's syndmeType II immediate hypesensitivityTH2ativated yttxi T eeffets f e-mediated immnitysevee mbined immndefiieny disease (SID)Type I hypesensitivityeffets f hma immnity
X
Immediate hypesensitivity type assiated with hemyti disease in the newbn
???ass I MH meestisteidsass II MH meesdeayed hypesensitivityhman immndefiieny visDiGege's syndmeType II immediate hypesensitivityTH2ativated yttxi T eeffets f e-mediated immnitysevee mbined immndefiieny disease (SID)Type I hypesensitivityeffets f hma immnity
X
Immediate hypesensitivity eatin assiated with asthma, hay feve, hives -- fwing bd basphi tisse mast e deganatin
???ass I MH meestisteidsass II MH meesdeayed hypesensitivityhman immndefiieny visDiGege's syndmeType II immediate hypesensitivityTH2ativated yttxi T eeffets f e-mediated immnitysevee mbined immndefiieny disease (SID)Type I hypesensitivityeffets f hma immnity
X
Fist-ass f hmna agents egnized t pssess ymphyti ppeties
Immnphamagy
This is a sef-gading exam. Answes ae enteed by iking the bttn espnding t y seetin. The examinatin is sed by iking 'Gade Test' at the bttm f the fm. et answes ae fnd thgh hypeinks at the bttm f the page.
أعلى النموذج
Qestin # 1 (Mtipe hie) Stta anagantimetabite: yttxi immnsppessive dg:
A) vinistine
B) yphsphamide
) azathipine
D) nne f the abve
Qestin # 2 (Mtipe hie) Immnmdaty sedative dgs sed in the management f sme fms f epsy; as effetive in managing skin manifestatins f ps eythematss
A) taims
B) yphsphamide
) thaidmide
D) bppin
E) diazepam
Qestin # 3 (Mtipe hie) Dg f hie in teating atimmne hemyti anemia:
A) yphsphamide ps fat XIII
B) h(D) immne gbin
) pednisne
D) KT3 mnna antibdy
E) yspine
Qestin # 4 (Mtipe hie) Intefees with e ye f ativated ymphid es;exampe f the fist ass f hmna agents egnized have ymphyti ppeties:
A) yspine
B) taims
) IFN-apha
D) dexamethasne
E) 15-desxyspegain
Qestin # 5 (Mtipe hie) sef in management f idipathi thmbytpeni ppa efaty t pednisne
A) datinmyin
B) vinistine
) yphsphamide
D) azathipine
E) a f the abve
Qestin # 6 (Mtipe hie) Dg f hie in teating hemyti anemia f the newbn:
A) yspine
B) pednisne
) KT3 mnna antibdy
D) taims
E) h(D) immne gbin
Qestin # 7 (Mtipe hie) inia ses f intefen:
A) ane teatment
B) mtipe sesis
) bth
D) neithe
Qestin # 8 (TeFase) Type 1 hypesensitivity: ss-inking f membane-bnd IgE n bd basphis tisse mast es by antigen
A) te
B) fase
Qestin # 9 (Mtipe hie) immnmdating agents:
A) thymsin
B) intefen beta
) intefen-gamma
D) TNF apha
E) a the abve
Qestin # 10 (TeFase) ass 1 MH mees pesent mainy fagments f ea antigens
A) te
B) fase
Qestin # 11 (Mtipe hie) Inhibits antigen egnitin f B-e
A) pednisne
B) azathipine
) methtexate
D) h(D) immne gbin
E) taims
Qestin # 12 (Mtipe hie) Antiymphyte antibdies:
A) binds t the sfae f T es
B) ats mainy n sma, ng-ived peiphea ymphytes
) may be sed in indtin f immnsppessin
D) may be btained by hybidma tehniqe f mnna antibdy geneatin
E) a f the abve
Qestin # 13 (Mtipe hie) inia ses f immnsppessive dgs:
A) gan tanspantatin
B) hemyti disease f the newbn
) atimmne disdes
D) A &
E) A, B &
أسفل النموذج